Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Updates in the Management of Migraine Headache: New Options to Enhance Outcomes

Migraine is a debilitating neurologic disorder that occurs in about 17% of women and 6% of men in the United States. It affects all aspects of life—from work and school attendance and performance to family life, leisure time, personal relationships, and finances. Unfortunately, migraine is often underdiagnosed and undertreated. This program will review the symptoms of and diagnostic criteria for migraine, appropriate use of traditional therapies, and the role of new and emerging therapies in the management of patients with episodic and chronic migraine. 
Nada Hindiyeh, MD
Susan M. Tiso, DNP, APRN, FNP-BC
Released: January 24, 2020

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Identify patients with migraine based on symptomatology and diagnostic criteria
  • Implement evidence-based strategies for the treatment and prevention of episodic and chronic migraine
  • Utilize efficacy and safety evidence to identify the appropriate role of new and emerging therapies for patients with migraine

Information on this Educational Activity


Nada Hindiyeh, MD

Clinical Assistant Professor
Department of Neurology
Stanford University
Palo Alto, California

Dr Hindiyeh: speaker: Amgen, Lilly.
Susan M. Tiso, DNP, APRN, FNP-BC

Clinical Professor

Master of Science/Nurse Practitioner Programs
Sue & Bill Gross School of Nursing
University of California, Irvine
Irvine, California

Dr Tiso has no relevant financial relationships to disclose.

Target Audience

NPs and PAs

Program Medium

This program has been made available online.

Related Content

From CCO: Companion Migraine Comorbidities slideset with highlights from Do-It-Better RealCME on Improving Migraine Treatment, and Prevention.

Jessica Ailani, MD Released: June 25, 2020

From CCO: companion migraine prophylaxis slideset with highlights from Do-It-Better RealCME on improving migraine treatment, and prevention

Wade Cooper, DO Released: June 25, 2020

Patient cases on migraine prophylaxis: beta-blockers, antiseizure medications, CGRP monoclonal antibodies (mAbs), role of shared decision-making

Wade Cooper, DO Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: May 28, 2020 Expired: May 28, 2021

Patient cases on comorbidities in migraine, including sleep disorders, depression, and more

Jessica Ailani, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: May 28, 2020 Expired: May 28, 2021
Provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine

Boston University School of Medicine
Continuing Medical Education
72 East Concord Street, A402
Boston, Massachusetts 02118

(617) 638-4605
(617) 638-4905 (Fax)

This activity is supported by an educational grant from
Teva Pharmaceuticals

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?